352 related articles for article (PubMed ID: 24787905)
1. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
[TBL] [Abstract][Full Text] [Related]
3. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
[TBL] [Abstract][Full Text] [Related]
4. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
5. Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic Hypogonadism.
Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
Int J Endocrinol; 2013; 2013():816740. PubMed ID: 24454369
[TBL] [Abstract][Full Text] [Related]
6. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.
Stanworth RD; Akhtar S; Channer KS; Jones TH
Eur J Endocrinol; 2014 Feb; 170(2):193-200. PubMed ID: 24165020
[TBL] [Abstract][Full Text] [Related]
7. Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men?
Lapauw B; Goemaere S; Crabbe P; Kaufman JM; Ruige JB
Eur J Endocrinol; 2007 Mar; 156(3):395-401. PubMed ID: 17322500
[TBL] [Abstract][Full Text] [Related]
8. Possible role of
Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of testosterone replacement therapy.
Zitzmann M
Pharmacogenomics; 2009 Aug; 10(8):1341-9. PubMed ID: 19663677
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes.
Stanworth RD; Kapoor D; Channer KS; Jones TH
Eur J Endocrinol; 2008 Dec; 159(6):739-46. PubMed ID: 18805913
[TBL] [Abstract][Full Text] [Related]
11. Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study.
Zitzmann M; Depenbusch M; Gromoll J; Nieschlag E
J Clin Endocrinol Metab; 2003 May; 88(5):2049-54. PubMed ID: 12727953
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of gonadotropin administration for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism and therapeutic measures.
Giagulli VA; Triggiani V; Corona G; Carbone MD; Tafaro E; Licchelli B; Resta F; Sabbà C; Maggi M; Guastamacchia E
Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):236-42. PubMed ID: 22385118
[TBL] [Abstract][Full Text] [Related]
13. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism.
Crabbe P; Bogaert V; De Bacquer D; Goemaere S; Zmierczak H; Kaufman JM
J Clin Endocrinol Metab; 2007 Sep; 92(9):3604-10. PubMed ID: 17579205
[TBL] [Abstract][Full Text] [Related]
14. CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?
Francomano D; Greco EA; Lenzi A; Aversa A
J Sex Med; 2013 Oct; 10(10):2373-81. PubMed ID: 23844628
[TBL] [Abstract][Full Text] [Related]
15. The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study.
Nielsen TL; Hagen C; Wraae K; Bathum L; Larsen R; Brixen K; Andersen M
Eur J Endocrinol; 2010 Apr; 162(4):795-804. PubMed ID: 20133446
[TBL] [Abstract][Full Text] [Related]
16. Anthropometry in Klinefelter syndrome--multifactorial influences due to CAG length, testosterone treatment and possibly intrauterine hypogonadism.
Chang S; Skakkebæk A; Trolle C; Bojesen A; Hertz JM; Cohen A; Hougaard DM; Wallentin M; Pedersen AD; Østergaard JR; Gravholt CH
J Clin Endocrinol Metab; 2015 Mar; 100(3):E508-17. PubMed ID: 25514102
[TBL] [Abstract][Full Text] [Related]
17. Effects of testosterone replacement and its pharmacogenetics on physical performance and metabolism.
Zitzmann M
Asian J Androl; 2008 May; 10(3):364-72. PubMed ID: 18385898
[TBL] [Abstract][Full Text] [Related]
18. Bone benefits of testosterone replacement therapy in male hypogonadism.
Tirabassi G; Biagioli A; Balercia G
Panminerva Med; 2014 Jun; 56(2):151-63. PubMed ID: 24994579
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
Zitzmann M; Nieschlag E
J Clin Endocrinol Metab; 2007 Oct; 92(10):3844-53. PubMed ID: 17635942
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
